Segui
Emilio Russo
Emilio Russo
University Magna Grecia of Catanzaro
Email verificata su unicz.it - Home page
Titolo
Citata da
Citata da
Anno
Nonpsychotropic plant cannabinoids, cannabidivarin (CBDV) and cannabidiol (CBD), activate and desensitize transient receptor potential vanilloid 1 (TRPV1) channels in vitro …
FA Iannotti, CL Hill, A Leo, A Alhusaini, C Soubrane, E Mazzarella, ...
ACS chemical neuroscience 5 (11), 1131-1141, 2014
4202014
Phthalates: European regulation, chemistry, pharmacokinetic and related toxicity
P Ventrice, D Ventrice, E Russo, G De Sarro
Environmental toxicology and pharmacology 36 (1), 88-96, 2013
3422013
Hypericum perforatum: Pharmacokinetic, Mechanism of Action, Tolerability, and Clinical Drug–Drug Interactions
E Russo, F Scicchitano, BJ Whalley, C Mazzitello, M Ciriaco, S Esposito, ...
Phytotherapy research 28 (5), 643-655, 2014
2752014
Corticosteroid-related central nervous system side effects
M Ciriaco, P Ventrice, G Russo, M Scicchitano, G Mazzitello, ...
Journal of Pharmacology and Pharmacotherapeutics 4 (1_suppl), S94-S98, 2013
2612013
Metformin and autoimmunity: a “new deal” of an old drug
F Ursini, E Russo, G Pellino, S D’Angelo, A Chiaravalloti, G De Sarro, ...
Frontiers in immunology 9, 1236, 2018
1912018
Epilepsy in cerebrovascular diseases: review of experimental and clinical data with meta‐analysis of risk factors
E Ferlazzo, S Gasparini, E Beghi, C Sueri, E Russo, A Leo, A Labate, ...
Epilepsia 57 (8), 1205-1214, 2016
1882016
Adherence to therapy and adverse drug reactions: is there a link?
C Leporini, G De Sarro, E Russo
Expert opinion on drug safety 13 (sup1), 41-55, 2014
1832014
mTOR pathway inhibition as a new therapeutic strategy in epilepsy and epileptogenesis
R Citraro, A Leo, A Constanti, E Russo, G De Sarro
Pharmacological research 107, 333-343, 2016
1762016
Microbiota-gut brain axis involvement in neuropsychiatric disorders
LF Iannone, A Preda, HM Blottière, G Clarke, D Albani, V Belcastro, ...
Expert review of neurotherapeutics 19 (10), 1037-1050, 2019
1672019
Targeting mast cells tryptase in tumor microenvironment: a potential antiangiogenetic strategy
M Ammendola, C Leporini, I Marech, CD Gadaleta, G Scognamillo, ...
BioMed research international 2014 (1), 154702, 2014
1402014
mTOR inhibition modulates epileptogenesis, seizures and depressive behavior in a genetic rat model of absence epilepsy
E Russo, R Citraro, G Donato, C Camastra, R Iuliano, S Cuzzocrea, ...
Neuropharmacology 69, 25-36, 2013
1382013
Limitations and obstacles of the spontaneous adverse drugs reactions reporting: Two “challenging” case reports
C Palleria, C Leporini, S Chimirri, G Marrazzo, S Sacchetta, L Bruno, ...
Journal of Pharmacology and Pharmacotherapeutics 4 (1_suppl), S66-S72, 2013
1192013
Antiepileptic action of N-palmitoylethanolamine through CB1 and PPAR-α receptor activation in a genetic model of absence epilepsy
R Citraro, E Russo, F Scicchitano, CM van Rijn, D Cosco, C Avagliano, ...
Neuropharmacology 69, 115-126, 2013
1172013
Cannabidiol and epilepsy: Rationale and therapeutic potential
A Leo, E Russo, M Elia
Pharmacological research 107, 85-92, 2016
1142016
Rare and very rare adverse effects of clozapine
P De Fazio, R Gaetano, M Caroleo, G Cerminara, F Maida, A Bruno, ...
Neuropsychiatric disease and treatment, 1995-2003, 2015
1142015
Upholding WAG/Rij rats as a model of absence epileptogenesis: Hidden mechanisms and a new theory on seizure development
E Russo, R Citraro, A Constanti, A Leo, A Lüttjohann, G van Luijtelaar, ...
Neuroscience & Biobehavioral Reviews 71, 388-408, 2016
1132016
The mTOR signaling pathway in the brain: focus on epilepsy and epileptogenesis
E Russo, R Citraro, A Constanti, G De Sarro
Molecular neurobiology 46, 662-681, 2012
1062012
Discovery of a novel and highly potent noncompetitive AMPA receptor antagonist
R Gitto, ML Barreca, L De Luca, G De Sarro, G Ferreri, S Quartarone, ...
Journal of medicinal chemistry 46 (1), 197-200, 2003
1052003
Liraglutide prevents cognitive decline in a rat model of streptozotocin-induced diabetes independently from its peripheral metabolic effects
C Palleria, A Leo, F Andreozzi, R Citraro, M Iannone, R Spiga, G Sesti, ...
Behavioural brain research 321, 157-169, 2017
1012017
Pharmacovigilance in Italy: an overview
C Mazzitello, S Esposito, AE De Francesco, A Capuano, E Russo, ...
Journal of Pharmacology and Pharmacotherapeutics 4 (1_suppl), S20-S28, 2013
1012013
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20